Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Valtoco (diazepam) and Nayzilam (midazolam) are both benzodiazepines used to treat seizure attacks in people with epilepsy, but they have some key differences. Valtoco is approved for use in children as young as 6 years old, while Nayzilam is only for those 12 and older. Valtoco comes in multiple doses (5 mg, 10 mg, 15 mg, and 20 mg), whereas Nayzilam is available in a single 5 mg dose. Valtoco can be used up to twice in a 24-hour period, and Nayzilam allows for a second dose if the seizure isn't controlled after 10 minutes. Both medications are nasal sprays and work quickly, but Valtoco typically works within 4 minutes, while Nayzilam can take up to 10 minutes. Additionally, Valtoco and Nayzilam are only available as a brand-name medication. Common side effects for both include drowsiness, headache, and nasal discomfort.
Valtoco (diazepam)
Nayzilam (midazolam)
Valtoco (diazepam)
Nayzilam (midazolam)
Summary of Valtoco vs. Nayzilam
Summary for Benzodiazepine
Prescription only
Valtoco (diazepam) is a fast-acting prescription medication used for short-term treatment of frequent seizure activity in adults and children 2 years and older. It comes as a ready-to-use nasal spray device, and your dose depends on your age and weight. Your prescriber will give you instructions on how to use the spray. Since it's a benzodiazepine, it's classified as a controlled substance. Side effects include feeling sleepy, headache, and nasal discomfort.
Summary for Benzodiazepine
Prescription only
Nayzilam (midazolam) is a nasal spray that quickly treats seizure attacks in people with a seizure condition called epilepsy. It comes in a ready-to-use spray device, but the person giving the medication must know when and how to give it properly. Nayzilam (midazolam) commonly causes drowsiness, throat irritation, and nasal discomfort. Nayzilam (midazolam) is only available as a brand-name medication.
Indications of Valtoco vs. Nayzilam
Indications for
•Short-term treatment of frequent seizures activity in people with epilepsy who are 2 years and older
Indications for
•Seizure attacks in people with epilepsy who are 12 years of age and older